Influence of beta-blockers on melatonin release

被引:162
作者
Stoschitzky, K
Sakotnik, A
Lercher, P
Zweiker, R
Maier, R
Liebmann, P
Lindner, W
机构
[1] Graz Univ, Med Klin, A-8036 Graz, Austria
[2] Univ Vienna, Inst Analyt Chem, Vienna, Austria
[3] Karl Franzens Univ Graz, Inst Gen & Expt Pathol, Graz, Austria
[4] Karl Franzens Univ Graz, Dept Med, Div Cardiol, Graz, Austria
基金
奥地利科学基金会;
关键词
stereoselectivity; chirality; melatonin;
D O I
10.1007/s002280050604
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: Melatonin is a mediator in the establishment of the circadian rhythm of biological processes. It is produced in the pineal gland mainly during the night by stimulation of adrenergic beta(1)- and alpha(1)-receptors. Sleep disturbances are common side-effects of beta-blockers. The influence of specific beta-blockade as well as that of combined alpha-and beta-blockade on melatonin production has not been investigated in humans before. Methods: We performed a randomized, double-blind; placebo-controlled, cross-over study in 15 healthy volunteers. Subjects received single oral doses of 40 mg (R)-propranolol, 40 mg (S)-propranolol, 50 mg (R)-atenolol, 50 mg (S)-atenolol, 25 mg (R,S)-carvedilol, 120 mg (R,S)-verapamil or placebo at 1800 hours. Urine was collected between 2200 hours and 0600 hours, and 6-sulfatoxy-melatonin (aMT6s), the main metabolite of melatonin which is almost completely eliminated in urine, was determined by radioimmunoassay (RIA). Results: Mean nocturnal excretion of aMT6s in urine after intake of the drugs was as follows (in mu g): placebo 26; (R)-propranolol 24 (-7%, NS); (S)-propranolol 5 (-80%, P < 0.001); (R)-atenolol 27 (+7%, NS); (S)atenolol 4 (-86%, P < 0.01); (R,S)-carvedilol 23 (-10%, NS); (R,S)-verapamil 29 (+14%, NS). These data show that only the specifically beta-blocking (S)-enantiomers of propranolol and atenolol decrease the nocturnal production of melatonin whereas the non-beta-blocking (R)-enantiomers have no effect. Unexpectedly, (R,S)-carvedilol which inhibits both alpha- and beta-adrenoceptors does not decrease melatonin production. Conclusion: These findings indicate that beta-blockers decrease melatonin release via specific inhibition of adrenergic beta(1)-receptors. Since lower nocturnal melatonin levels might be the reason for sleep disturbances, further clinical studies should investigate whether or not oral administration of melatonin might avoid this well-known side-effect of beta-blockers. The reason why (R,S)-carvedilol does not influence melatonin production remains to be determined.
引用
收藏
页码:111 / 115
页数:5
相关论文
共 32 条
[1]   IMMUNOASSAY OF 6-HYDROXYMELATONIN SULFATE IN HUMAN-PLASMA AND URINE - ABOLITION OF THE URINARY 24-HOUR RHYTHM WITH ATENOLOL [J].
ARENDT, J ;
BOJKOWSKI, C ;
FRANEY, C ;
WRIGHT, J ;
MARKS, V .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 60 (06) :1166-1173
[2]   CAFFEINE AND PROPRANOLOL BLOCK THE INCREASE IN RAT PINEAL MELATONIN PRODUCTION PRODUCED BY STIMULATION OF ADENOSINE RECEPTORS [J].
BABEY, AM ;
PALMOUR, RM ;
YOUNG, SN .
NEUROSCIENCE LETTERS, 1994, 176 (01) :93-96
[3]  
BOJKOWSKI CJ, 1987, CLIN CHEM, V33, P1343
[4]  
BRISMAR K, 1988, ACTA MED SCAND, V223, P525
[5]  
BRISMAR K, 1987, ACTA MED SCAND, V221, P155
[6]   RECEPTOR PHARMACOLOGY OF CARVEDILOL IN THE HUMAN HEART [J].
BRISTOW, MR ;
LARRABEE, P ;
MINOBE, W ;
RODEN, R ;
SKERL, L ;
KLEIN, J ;
HANDWERGER, D ;
PORT, JD ;
MULLERBECKMANN, B .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 19 :S68-S80
[7]  
Brzezinski Amnon, 1997, New England Journal of Medicine, V336, P186
[8]   CELLULAR AND MOLECULAR MECHANISMS CONTROLLING MELATONIN RELEASE BY MAMMALIAN PINEAL GLANDS [J].
CARDINALI, DP ;
VACAS, MI .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 1987, 7 (04) :323-337
[9]   TREATMENT WITH BETA-ADRENOCEPTOR BLOCKERS REDUCES PLASMA MELATONIN CONCENTRATION [J].
COWEN, PJ ;
BEVAN, JS ;
GOSDEN, B ;
ELLIOTT, SA .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 19 (02) :258-260
[10]   DOSE-EFFECT AND PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS OF THE BETA(1)-ADRENERGIC RECEPTOR BLOCKING PROPERTIES OF VARIOUS DOSES OF CARVEDILOL IN HEALTHY HUMANS [J].
DEMEY, C ;
BREITHAUPT, K ;
SCHLOOS, J ;
NEUGEBAUER, G ;
PALM, D ;
BELZ, GG .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (03) :329-337